Malignancies

1 minute read

Business

Accutar Biotechnology Announces First Patient Dosed with AC0676 in Phase 1 Study in Patients with Relapsed/Refractory B-cell Malignancies

CRANBURY, N.J. — Accutar Biotechnology, Inc., a biotechnology company focusing on artificial intelligence (AI)-empowered drug discovery, today announced…

bySarjatha Shahinlal

June 21, 2023

No comments

The Latest

Brinley Forms $4 Billion Partnership with Leading Insurer, Launches $1 Billion CLO

Emaar The Economic City & Al Tahaluf Sign Deal to Deliver New Residential Projects in KAEC’s Al Murooj

Uptime’s 15th Annual Global Data Center Survey Results Show Both Commitment and Hesitancy as Industry Plans for Wider AI Usage, Climate Change Reporting, and the NVIDIA Revolution to Come

TELUS Digital Expands into the Middle East with Opening of Dubai Office

Accutar Biotechnology Announces First Patient Dosed with AC0676 in Phase 1 Study in Patients with Relapsed/Refractory B-cell Malignancies

Brinley Forms $4 Billion Partnership with Leading Insurer, Launches $1 Billion CLO

Emaar The Economic City & Al Tahaluf Sign Deal to Deliver New Residential Projects in KAEC’s Al Murooj

Uptime’s 15th Annual Global Data Center Survey Results Show Both Commitment and Hesitancy as Industry Plans for Wider AI Usage, Climate Change Reporting, and the NVIDIA Revolution to Come

TELUS Digital Expands into the Middle East with Opening of Dubai Office

LG Unveils Exclusive Summer Savings to Elevate Every Moment of the Season

Gulf Scientific Corporation Announces Strategic Partnership with NETZSCH Analyzing & Testing to Represent Advanced Material Characterization Techniques in KSA, UAE & Oman

Saviynt Accelerates Global Expansion in Asia Pacific, Japan, Europe, and the Middle East

LG Revolutionizes Workplace Flexibility with Launch of Smart Monitor Swing in Gulf Region